Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBYOT.L Share News (BYOT)

  • There is currently no data for BYOT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Small caps round-up: Ark Therapeutics, Hambledon, Nighthawk ...

Tue, 08th Feb 2011 14:28

Drug developer Ark Therapeutics has sold the majority of its wound care business to Crawford Healthcare for up to £2.7m, comprising £0.77m upfront and up to £1.93m in milestone payments.The value of the gross assets being sold was put at £1,153,000 as at 30 June 2010. The losses on ordinary activities after tax attributable to the sold businesses was £428,000.Hambledon is increasing planned output from an underground mine currently being built at its Sekisovskoye operations in Kazakhstan.First ore is due to be extracted from underground in December and the extraction rate is now expected to grow to 850,000 tonnes per annum (tpa) over five years compared with the initial plan for 500,000tpa. Gold production from the underground mine alone is targeted to incrementally reach 65,000 ounces in 2014 and 110,000 ounces in 2016. Net production at oil company Nighthawk fell to 3,086 barrels of oil in the fourth quarter of 2010 from 4,092 barrels during the previous three months.It blamed the decline on more work-overs and recompletions in the period and said first quarter output will be broadly in line with December's number.Byotrol, the developer of anti microbial hygiene technologies, has extended its pact with own-label producer McBride to jointly develop and sell residual action liquid disinfectants in the European market. It is now expected that the first product will be launched in the first half of 2011. Byotrol and McBride intend to enter into full licence agreements, with UK product launches of Byotrol-based household care products expected in the third and fourth quarters of 2011. Home care operator Southern Cross Healthcare saw revenue dip in the final quarter of 2010 to £236.3m from £240.5m (restated) the year before, while the average occupancy rate on a like for like basis declined to 87.6% from 90.7% a year earlier.Adjusted earnings before interest, tax, depreciation and amortisation tumbled to £5.0m from a restated £14.4m in the corresponding period of 2009. Net debt during the quarter rose £14.1m to £21.4m. The group continues to engage with Landlords in pursuit of a restructuring of its lease terms and will provide a further update on this subject in due course.
More News
1 Oct 2021 09:03

Byotrol sells surface spray formulation to Integrated Resources

Byotrol sells surface spray formulation to Integrated Resources

Read more
19 Aug 2021 14:14

IN BRIEF: Byotrol warns sanitiser sales set to drop after record year

IN BRIEF: Byotrol warns sanitiser sales set to drop after record year

Read more
12 Aug 2021 16:04

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
21 Jun 2021 21:28

IN BRIEF: Byotrol backs new UK regulations on alcohol-free sanitisers

IN BRIEF: Byotrol backs new UK regulations on alcohol-free sanitisers

Read more
22 Apr 2021 18:33

TRADING UPDATES: Bank of Georgia wins Pipia case; MGC buys MediCaNL

TRADING UPDATES: Bank of Georgia wins Pipia case; MGC buys MediCaNL

Read more
22 Apr 2021 11:43

AIM WINNERS & LOSERS: Renalytix jumps on contract with US government

AIM WINNERS & LOSERS: Renalytix jumps on contract with US government

Read more
26 Feb 2021 17:57

LONDON TRADING UPDATES: Castings Hails Return To Pre-Covid Levels

LONDON TRADING UPDATES: Castings Hails Return To Pre-Covid Levels

Read more
7 Dec 2020 14:10

Byotrol Reports Positive Interim Results On Pandemic-Driven Demand

Byotrol Reports Positive Interim Results On Pandemic-Driven Demand

Read more
13 Nov 2020 14:50

Byotrol Confident As Annual Results To Meet Expectations

Byotrol Confident As Annual Results To Meet Expectations

Read more
13 Nov 2020 08:35

Byotrol trading 'remains healthy', in line with FY expectations

(Sharecast News) - Infection prevention and control company Byotrol said on Friday that trading had remained at "healthy levels" across all business units and product sales.

Read more
6 Nov 2020 16:54

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
24 Sep 2020 14:51

IN BRIEF: Byotrol Swings To Annual Loss On Higher Expenses

IN BRIEF: Byotrol Swings To Annual Loss On Higher Expenses

Read more
7 Sep 2020 13:53

IN BRIEF: Byotrol Gets GBP350,000 Grant For Anti-Viral Uses Of Seaweed

IN BRIEF: Byotrol Gets GBP350,000 Grant For Anti-Viral Uses Of Seaweed

Read more
7 Sep 2020 09:15

Byotrol gets ?0.35m grant for seaweed research

(Sharecast News) - Specialist infection prevention company Byotrol has secured a "significant" £0.35m grant from Innovate UK, it announced on Monday, to further investigate the anti-viral properties of certain common forms of seaweed.

Read more
3 Aug 2020 18:22

UK TRADING UPDATE SUMMARY: Tiziana Offering to Raise GBP57 Million

UK TRADING UPDATE SUMMARY: Tiziana Offering to Raise GBP57 Million

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.